These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms. Taniguchi T; Sumitani S; Aono M; Iga J; Kinouchi S; Aki H; Matsushita M; Taniguchi K; Tsuno M; Yamanishi K; Tomotake M; Kaneda Y; Ohmori T Hum Psychopharmacol; 2006 Oct; 21(7):439-45. PubMed ID: 17029303 [TBL] [Abstract][Full Text] [Related]
24. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
25. Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia. Mittal VA; Neumann C; Saczawa M; Walker EF Arch Gen Psychiatry; 2008 Feb; 65(2):165-71. PubMed ID: 18250254 [TBL] [Abstract][Full Text] [Related]
26. Metaclopramide neurotoxicity. Santos A; Arana G J S C Med Assoc; 1988 Nov; 84(11):542-5. PubMed ID: 3059051 [No Abstract] [Full Text] [Related]
27. An interview with Jeffrey A. Lieberman: Tardive Dyskinesia. [interview by Sussman Norman]. Lieberman JA CNS Spectr; 2007 Oct; 12(10):747-50. PubMed ID: 18018327 [No Abstract] [Full Text] [Related]
28. [Psychopathology of schizophrenia and brain imaging]. Gross G; Huber G Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545 [TBL] [Abstract][Full Text] [Related]
34. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia. Chino B; Nemoto T; Fujii C; Mizuno M Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107 [TBL] [Abstract][Full Text] [Related]
35. Overlap between emotional blunting, depression, and extrapyramidal symptoms in schizophrenia. Müller M Schizophr Res; 2002 Oct; 57(2-3):307. PubMed ID: 12223263 [No Abstract] [Full Text] [Related]
36. Gait disturbances in patients with schizophrenia and adaptation to treadmill walking. Putzhammer A; Perfahl M; Pfeiff L; Hajak G Psychiatry Clin Neurosci; 2005 Jun; 59(3):303-10. PubMed ID: 15896224 [TBL] [Abstract][Full Text] [Related]
37. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness. Honer WG; Kopala LC; Rabinowitz J J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513 [TBL] [Abstract][Full Text] [Related]
38. Standardized assessment of psychopathology by relatives of mentally disordered patients. Preliminary results of using the positive and negative syndrome scale to compare schizophrenic and affective disorders. Nitsche I; Kallert TW Psychopathology; 2007; 40(4):242-53. PubMed ID: 17440287 [TBL] [Abstract][Full Text] [Related]
39. The basal ganglia and cognitive pattern generators. Graybiel AM Schizophr Bull; 1997; 23(3):459-69. PubMed ID: 9327509 [TBL] [Abstract][Full Text] [Related]